| Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1 CL Au Yeung, NN Co, T Tsuruga, TL Yeung, SY Kwan, CS Leung, Y Li, ... Nature communications 7 (1), 11150, 2016 | 685 | 2016 |
| TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment TL Yeung, CS Leung, KK Wong, G Samimi, MS Thompson, J Liu, TM Zaid, ... Cancer research 73 (16), 5016-5028, 2013 | 413 | 2013 |
| Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis TL Yeung, CS Leung, KP Yip, CL Au Yeung, STC Wong, SC Mok American Journal of Physiology-Cell Physiology 309 (7), C444-C456, 2015 | 368 | 2015 |
| Targeting stromal glutamine synthetase in tumors disrupts tumor microenvironment-regulated cancer cell growth L Yang, A Achreja, TL Yeung, LS Mangala, D Jiang, C Han, J Baddour, ... Cell metabolism 24 (5), 685-700, 2016 | 350 | 2016 |
| Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential CS Leung, TL Yeung, KP Yip, S Pradeep, L Balasubramanian, J Liu, ... Nature communications 5 (1), 5092, 2014 | 120 | 2014 |
| Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance CS Leung, TL Yeung, KP Yip, KK Wong, SY Ho, LS Mangala, AK Sood, ... The Journal of clinical investigation 128 (2), 589-606, 2018 | 115 | 2018 |
| Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion Y Lan, M Moustafa, M Knoll, C Xu, J Furkel, A Lazorchak, TL Yeung, ... Cancer cell 39 (10), 1388-1403. e10, 2021 | 106 | 2021 |
| Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer TM Zaid, TL Yeung, MS Thompson, CS Leung, T Harding, NN Co, ... Clinical Cancer Research 19 (4), 809-820, 2013 | 104 | 2013 |
| ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells TL Yeung, CS Leung, KK Wong, A Gutierrez-Hartmann, J Kwong, ... Oncotarget 8 (10), 16951, 2017 | 97 | 2017 |
| Mesothelial‐to‐mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer A Rynne‐Vidal, CL Au‐Yeung, JA Jiménez‐Heffernan, ML Pérez‐Lozano, ... The Journal of pathology 242 (2), 140-151, 2017 | 93 | 2017 |
| Targeting stromal-cancer cell crosstalk networks in ovarian cancer treatment TL Yeung, CS Leung, F Li, STC Wong, SC Mok Biomolecules 6 (1), 3, 2016 | 50 | 2016 |
| Anticancer immunotherapy by MFAP5 blockade inhibits fibrosis and enhances chemosensitivity in ovarian and pancreatic cancer TL Yeung, CS Leung, KP Yip, J Sheng, L Vien, LC Bover, MJ Birrer, ... Clinical Cancer Research 25 (21), 6417-6428, 2019 | 48 | 2019 |
| Systematic identification of druggable epithelial–stromal crosstalk signaling networks in ovarian cancer TL Yeung, J Sheng, CS Leung, F Li, J Kim, SY Ho, MM Matzuk, KH Lu, ... JNCI: Journal of the National Cancer Institute 111 (3), 272-282, 2019 | 42 | 2019 |
| ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment CL Au-Yeung, TL Yeung, A Achreja, H Zhao, KP Yip, SY Kwan, M Onstad, ... Nature communications 11 (1), 3546, 2020 | 35 | 2020 |
| ISG15 promotes ERK1 ISGylation, CD8+ T cell activation and suppresses ovarian cancer progression TL Yeung, CC Tsai, CS Leung, CL Au Yeung, MS Thompson, KH Lu, ... Cancers 10 (12), 464, 2018 | 33 | 2018 |
| CAF reprogramming inhibits ovarian cancer progression TL Yeung, CS Leung, SC Mok Cell cycle 13 (24), 3783-3784, 2014 | 33 | 2014 |
| Ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) promotes uterine serous cancer cell proliferation and cell cycle progression SY Kwan, CL Au-Yeung, TL Yeung, A Rynne-Vidal, KK Wong, JI Risinger, ... Cancers 12 (1), 118, 2020 | 27 | 2020 |
| Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers HU Osmanbeyoglu, F Shimizu, A Rynne-Vidal, D Alonso-Curbelo, ... Nature communications 10 (1), 4369, 2019 | 27 | 2019 |
| Sio: A spatioimageomics pipeline to identify prognostic biomarkers associated with the ovarian tumor microenvironment Y Zhu, S Ferri-Borgogno, J Sheng, TL Yeung, JK Burks, P Cappello, ... Cancers 13 (8), 1777, 2021 | 23 | 2021 |
| Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature E Hinchcliff, C Paquette, J Roszik, S Kelting, MH Stoler, SC Mok, ... Cancer Immunology, Immunotherapy 68, 1515-1526, 2019 | 20 | 2019 |
